Seoulin Bioscience Market Cap

Seoulin Bioscience has a market cap or net worth of 55.96 billion as of April 30, 2026. Its market cap has decreased by -4.55% in one year.

Market Cap

55.96B

Enterprise Value

34.67B

Revenue

77.09B

Ranking

n/a

PE Ratio

115.27

Stock Price

6,450.00

Market Cap Chart

Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 55.96B, a decrease of -19.76%. That is a compound annual growth rate of -1.07%.

Market Cap History

Date	Market Cap	% Change
Apr 30, 2026	55.96B	-2.61%
Dec 30, 2025	57.46B	-6.51%
Dec 30, 2024	61.46B	-21.97%
Dec 28, 2023	78.77B	-19.25%
Dec 29, 2022	97.55B	-44.18%
Dec 30, 2021	174.75B	62.58%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Dx & Vx	453.26B
3billion	415.76B
Inventera	195.46B
GENINUS	182.56B
Cytogen	128.73B
HLB Panagene	99.35B
Green Cross Medical Science	85.23B
Protia	63.36B

Market Cap Rankings